Results 71 to 80 of about 1,565,970 (254)

Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis

Revista Brasileira de Reumatologia, 2012
OBJETIVO: Elaborar recomendações para o tratamento da artrite reumatoide no Brasil. MÉTODO: Revisão da literatura com seleção de artigos baseados em evidência e opinião de especialistas da Comissão de Artrite Reumatoide da Sociedade Brasileira de ...
Licia Maria Henrique da Mota, Boris Afonso Cruz, Claiton Viegas Brenol, Ivanio Alves Pereira, Lucila Stange Rezende-Fronza, Manoel Barros Bertolo, Max Victor Carioca de Freitas, Nilzio Antonio da Silva, Paulo Louzada-Júnior, Rina Dalva Neubarth Giorgi, Rodrigo Aires Corrêa Lima, Geraldo da Rocha Castelar Pinheiro   +11 more
doaj   +1 more source

Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells

Frontiers in Pharmacology, 2020
Mesenchymal stem cell (MSC)–based articular regeneration might be beneficial for both protecting and rebuilding cartilaginous tissues in the management of rheumatoid arthritis. However, it is unclear how current immunosuppressive strategies influence the
Shuang Liu, Takeshi Kiyoi, Marina Ishida, Masaki Mogi   +3 more
doaj   +1 more source

Psoriatic arthritis: A retrospective study of 162 patients [PDF]

Vojnosanitetski Pregled, 2005
Aim. The aim of our study was to determine the prevalence of psoriatic arthritis in the patients with psoriasis and to analyze retrospectively the results of a 34-year multidisciplinary management of the patients with psoriatic arthritis. Methods.
Pavlica Ljiljana, Perić-Hajzler Zorica, Jovelić Aleksandra, Šekler Boris, Damjanović Milorad   +4 more
doaj   +1 more source

Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

Arthritis &Rheumatology, EarlyView.
Objective To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. Methods We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA ...
Outi Sareila, Linda Johansson, Anders Lundquist, Monica Leu Agelii, Lei Cheng, Yibo He, Erik Lönnblom, Maria Andersson, Jan Kihlberg, Anders Esberg, Inger Gjertsson, Rikard Holmdahl, Solbritt Rantapää‐Dahlqvist   +12 more
wiley   +1 more source

Antirheumatic agents: CNS toxicity and its avoidance.

, 1989
Altered drug metabolism, polypharmacy, multiple diseases, and errors in self-medication are all factors seen in the elderly which increase the risk for side effects from antirheumatic drug therapy.
Bridges, C R, Regan-Smith, M G, Iobst, W F   +2 more
core   +1 more source

Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research

, 2012
Clinical manifestations of most rheumatic diseases have changed over the past few decades, largely due to advances in therapies targeting autoimmune and (auto)inflammatory pathways.
Ayvazyan, Lilit, Gasparyan, Armen Yuri, Cocco, Giuseppe, Kitas, George D.   +3 more
core   +1 more source

Connective tissue activation. IV. Regulatory effects of antirheumatic drugs [PDF]

, 1972
Cortisol, phenylbutazone, indomethacin, acetylsalicylic acid, meclofenamic acid, flufenamic acid and mefanamic acid were potent inhibitors of connective tissue activation, especially if introduced into synovial cultures within 2 hours of initiation of ...
Castor, C. William
core   +1 more source

Determinants of Difficult‐to‐Manage and Treatment‐Refractory Axial Spondyloarthritis: A Cross‐Sectional Analysis Within a Longitudinal Cohort

Arthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to estimate the prevalence of difficult‐to‐manage (D2M) and treatment‐refractory (TR) axial spondyloarthritis (axSpA) and to identify factors associated with D2M and TR disease in a longitudinal cohort. Methods We performed a cross‐sectional analysis on data from the Schroeder Arthritis Institute Spondylitis ...
Patricia Remalante‐Rayco, Laura Passalent, Tina Chim, Hannah Vijayan, Manal Alnasser, Zeynep Baskurt, Robert D. Inman, Nigil Haroon, Denis Poddubnyy   +8 more
wiley   +1 more source

Interações medicamentosas: uma contribuição para o uso racional de imunossupressores sintéticos e biológicos Drug interactions: a contribution to the rational use of synthetic and biological immunosuppressants

Revista Brasileira de Reumatologia, 2011
Interação medicamentosa é um evento clínico em que os efeitos de um fármaco são alterados pela presença de outro fármaco, fitoterápico, alimento, bebida ou algum agente químico ambiental.
Luiza Cristina Lacerda Jacomini, Nilzio Antonio da Silva   +1 more
doaj   +1 more source

Toxicity of Antirheumatic Drugs

, 1997
Pharmacological treatments can have a major impact on the outcome of rheumatic diseases. To achieve the best results, individual treatment regimens comprising analgesic agents, non-steroidal anti-inflammatory drugs and disease-modifying antirheumatic ...
Lehmann, T., Day, R. O., Brooks, P. M.
core